Reading Time: 3 minutes A recently published paper, reviewing 15 studies that investigated the effectiveness of riluzole as a treatment for MND in real-time, has suggested that the drug
Month: July 2020
Reading Time: 4 minutes Guest researcher blog post: My name is Sophie Nyberg and I am a neuroscientist currently working in the Lighthouse COVID-19 testing labs in Alderley Park,
Reading Time: 5 minutes Last Thursday marked an exciting milestone in the search for effective therapies for MND as full results from the early-phase 1/2 trial of Biogen’s tofersen
Reading Time: 4 minutes Although ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in